Fairvalue-Calculator Fairvalue-Calculator
EN DE

MeiHua Holdings (600873) Fair Value & Analysis

Basic Materials · CN · Market cap 25.1B CNY

Price¥8.25
Fair Value¥19.89
Upside+141.1%
Quality95/100
Evidence: High Range ¥14.58 – ¥43.57

Analysis

MeiHua Holdings (600873) currently trades at ¥8.25, while our model-based Fair Value estimate is ¥19.89 — implying the stock looks roughly 141.1% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

MeiHua Holdings Group Co.,Ltd, together with its subsidiaries, manufactures nutritional products and solutions in China and internationally. The company offers amino acids; l-threonine and l-lysine for livestock; umami agents comprising monosodium glutamate and I+G; food ingredients consisting of l-glutamine, l-proline, l-valine, isoleucine, adenosine, guanosine, and inosine; and colloids and polysaccharides, such as food-grade and industrial-grade xanthan gums, pullulan, and trehalose. It also provides livestock health products, including riboflavin, and feed-grade isoleucine and valine; plant-based protein, such as corn germ, corn gluten meal and feed, and MSG by-products; and organic fertilizers. In addition, the company engages in technological development; trading; investment; and warehousing. MeiHua Holdings Group Co.,Ltd was founded in 1995 and is based in Langfang, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.